The most well known circulating tumor cells (CTCs) enrichment approaches from whole blood samples utilize biological and/or physical CTC features, and mainly encompass size-based, positive and negative immune-affinity-based, and density-based methods or their combinations. Unfortunately, so far CTC technologies have not been fully and clinically made advantageous. Some of the most